Pune, Maharashtra -- (SBWIRE) -- 05/11/2018 -- The author of the report analyzed that the nuclear medicine market accounted for US$ 4.62 billion in 2016. Nuclear medicine is cost effective method for treatment and yields more accurate information than regular surgeries. They also enable early stage detection of diseases at early stages.

nuclear medicine market is mainly driven by development of new treatments for diagnosis and therapy for various diseases. A number of factors such as radiation risk and adverse effects from therapy can negatively impact the market. It has been reported that, these side effects are not long-term and potential risk from such therapies are on the lower side. The emerging markets such as India and China are expected to show higher adoption rate of nuclear medicines in the future.

Request For Sample PDF @ https://www.absolutemarketsinsights.com/request_sample.php?id=32

The report provides both, qualitative and quantitative research of the market, as well as it helps to gain important insights of current and future market and trending technologies adopted by the key players. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisitions(M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their manufacturing base, competitors, product type, application and specification, pricing, and gross margin.

Based on Product, Therapeutic Medicine Segment of the Nuclear Medicine Market Is Projected to be the Fastest Growing Segment During the Forecast Period, 2018-2026
Therapeutic medicine is further segmented into beta emitters, alpha emitters and brachytherapy isotopes. They are used in the treatment of cancer, cardiovascular diseases and neurological diseases. Also, therapeutic radionuclides such as phosphorous-32, yttrium-90, strontium-90 and iodine-131 are widely used in the treatment of malignant and benign disorders.

North America is Estimated to be the Largest Nuclear Medicine Market
The North American region held the largest market share for nuclear medicine in terms of revenue, in 2016. The growth of the North America market can be attributed to the widespread awareness of the use of radioisotopes and radiation in medicine for various medical conditions.

Get More Information @ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=32

Nuclear Medicine Market is Fragmented with the Presence of Global and Regional Players
Cardinal Health, Inc., Medtronic, Minimally Invasive Therapies, Ion Beam Applications S.A (IBA Worldwide), Lantheus Medical Imaging Inc., General Electric Company, Bracco Imaging S.p.A, Bayer AG, Advanced Medical Isotope Corporation, Alliance Medical Limited, Alseres Pharmaceuticals, Inc., Avid Radiopharmaceuticals, Inc., Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Jubilant Pharma LLC, Mallinckrodt Pharmaceuticals, Medi-Radiopharma Co., Ltd., Peregrine Pharmaceuticals, Inc.,Positron Corporation and Nordion (Canada) Inc. amongst others.

Purchase the complete report @ https://www.absolutemarketsinsights.com/checkout?id=32

Nuclear Medicine Market- By Product
Diagnostic Medicine
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
Therapeutic Medicine
Beta Emitters
Alpha Emitters
Brachytherapy Isotopes

Nuclear Medicine Market- By Application
Diagnostic Application
Oncology
Cardiology
Neurology
Therapeutic Application
Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors

Market By Region
North America
Europe
Asia Pacific
Rest of The World

Key points covered in this report:
Full in-depth analysis of the Nuclear Medicine Market
Important changes in market dynamics
Segmentation details of the market
Former, on-going, and projected market analysis in terms of volume and value
Market share analysis
Key strategies of major players
Emerging segments and regional markets